HALO logo
halo search icon
Citius Oncology, Inc.

US$0.83

Price Change Indicator
-0.0022 (-0.266%)
Citius Oncology, Inc.
CTOR · NAS

Citius Oncology, Inc.

Start Trading CTOR for Free

US$0.83

Price Arrow-0.0022 (-0.266%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Price MomentumHammer Bearish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Citius Oncology, Inc. Overview

CTOR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CTOR

icon

Website

Citius Oncology, Inc.

icon

Telephone

1.908.967.6677

icon

Address

1st floor, 11 Commerce Drive, Cranford, NJ 07016

Description

Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.

CTOR Price Chart

Key Stats

Market Cap

US$77.01M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.49 - 6.19

Trade Value (12mth)

US$359,987.00

1 week

-14.02%

1 month

-7.97%

YTD

-23.31%

1 year

-5.4%

All time high

49.00

Key Fundamentals

EPS 3 yr Growth

-900.90%

EBITDA Margin

0.00%

Operating Cashflow

-$5m

Free Cash Flow Return

-11.10%

ROIC

-50.20%

Interest Coverage

-107.90

Quick Ratio

0.10

Other Data

Shares Outstanding (Fully Diluted)

100m

HALO Sector

Other Finance

Next Company Report Date

17-Dec-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CTOR Announcements

Latest Announcements

DateAnnouncements
16 May 26
16 May 26
06 May 26
30 April 26
29 April 26

CTOR Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock0.27-0.31-0.34locklocklock
EPS (Fully Diluted)
 $locklocklocklock0.27-0.31-0.34locklocklock
Growth
 %locklocklocklock540.8-214.9-8.8locklocklock
PE
 Xlocklocklocklock40.5N/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Citius Oncology, Inc. (CTOR:NAS)?
Halo FAQ
The current share price of Citius Oncology, Inc. (CTOR:NAS) is USD$0.83.
What is the 52-week high share price for Citius Oncology, Inc. (CTOR:NAS)?
Halo FAQ
The 52-week high share price for Citius Oncology, Inc. (CTOR:NAS) is USD$6.19.
What is the 52-week low share price for Citius Oncology, Inc. (CTOR:NAS)?
Halo FAQ
The 52-week low share price for Citius Oncology, Inc. (CTOR:NAS) is USD$0.49.
What is the dividend yield for Citius Oncology, Inc. (CTOR:NAS)?
Halo FAQ
Citius Oncology, Inc. (CTOR:NAS) does not pay a dividend.
What was Citius Oncology, Inc. (CTOR:NAS) last dividend payment?
Halo FAQ
Citius Oncology, Inc. (CTOR:NAS) does not pay a dividend.
What is the franking level for Citius Oncology, Inc. (CTOR:NAS)?
Halo FAQ
Citius Oncology, Inc. (CTOR:NAS) has a franking level of 0.00%.
In which sector is Citius Oncology, Inc. (CTOR:NAS) classified?
Halo FAQ
Citius Oncology, Inc. (CTOR:NAS) is classified in the Other Finance.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial